Diabetic eye screening and glucagon-like peptide agonists: guidance

Diabetic eye screening: no extra screening is currently advised for rapid glucose improvement, including with GLP-1/GIP agonists, while evidence is reviewed.

NHS England · Primary Care Bulletin item

Diabetic eye screening and glucagon-like peptide agonists: guidance

Published 6 November 2025 · Prescribing & medicines, Referrals & hospital services

← NHS England Primary Care Bulletin – 6 November 2025

NHSENews

In brief Diabetic eye screening: no extra screening is currently advised for rapid glucose improvement, including with GLP-1/GIP agonists, while evidence is reviewed.

Read the full item in the bulletin ↗

From NHS England’s Primary Care Bulletin, issue 364, 6 November 2025. Headline is NHS England’s; summary by BLMC. The full bulletin is also published on patient.info.